Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy [PDF]
Journal of Transplantation, 2013 Background. No studies have evaluated the impact of multiple generic immunosuppression medications on transplant coordinators (TCs) and patients. Methods.
K. Parker +3 more
doaj +2 more sources
Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. [PDF]
PLoS ONE, 2013 Immunosuppression therapy following liver transplantation often includes steroids. However, extended corticosteroid therapy is associated with numerous complications.
Tonghai Xing +5 more
doaj +3 more sources
Gut microbiota modulation in cardiac cell therapy with immunosuppression in a nonhuman primate ischemia/reperfusion model [PDF]
npj Regenerative MedicineGut microbiota affect transplantation outcomes; however, the influence of immunosuppression and cell therapy on the gut microbiota in cardiovascular care remains unexplored.
Hung-Chih Chen +10 more
doaj +2 more sources
Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background Long‐term corticosteroid therapy is the standard of care for treatment of cardiac sarcoidosis (CS). The efficacy of long‐term corticosteroid‐sparing immunosuppression in CS is unknown.
David G. Rosenthal +17 more
doaj +3 more sources
Survival predictors in paraquat intoxification and role of immunosuppression [PDF]
Toxicology Reports, 2014 Paraquat poisoning resulted in multiorgan failure and is associated with high mortality. We audited 83 historical cases of paraquat poisoning in past 2 years treated with conventional decontamination and supportive treatment, followed by enrolling 85 ...
Keng-Hee Koh +10 more
doaj +2 more sources
Characteristics and immunosuppression therapy for SOT recipients. [PDF]
, 2022 Characteristics and immunosuppression therapy for SOT recipients.
Richard J. Knight (14279145) +14 more
core +1 more source
Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency [PDF]
, 2023 Ornithine transcarbamylase deficiency (OTCD) is the most common urea cycle disorder with high unmet needs, as current dietary and medical treatments may not be sufficient to prevent hyperammonemic episodes, which can cause death or neurological sequelae.
Berna Seker Yilmaz, Paul Gissen
core +1 more source
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics. [PDF]
, 2012 The immunosuppressive drugs used to prevent the rejection of transplanted organs have a narrow therapeutic index. Under treatment results in episodes of rejection leading to either damage or loss of the organ. Over immunosuppression increases the risk of
MacPhee IA +3 more
core +1 more source
Medicina, 2023 (1) Introduction: Liver transplantation represents the gold-standard therapy in eligible patients with acute liver failure or end-stage liver disease.
Gabriela Droc +5 more
doaj +1 more source
Immunosuppressive Drug Therapy [PDF]
Cold Spring Harbor Perspectives in Medicine, 2013 The first successful kidney transplantation between monozygotic identical twins did not require any immunosuppressive drugs. Clinical application of azathioprine and glucocorticosteroids allowed the transfer of organs between genetically disparate donors and recipients.
Choli, Hartono +2 more
openaire +2 more sources